EUVIMEDEUVIMED entdecken
Editorial

Editorial for “Clinicopathologic and Prognostic Differences Between LI ‐ RADS M Targetoid and LI ‐ RADS M Nontargetoid Observations: A Comparative Imaging‐Based Study”

Leandro Tristao, Christian B van der Pol iD

Journal of Magnetic Resonance Imaging · 2026-06 · 63 (6) · 1711-1712

DOI: 10.1002/jmri.70290 ↗

Kurz gefasst

Editorial in der Zeitschrift Journal of Magnetic Resonance Imaging, online erschienen am 09.03.2026. Verfasst von Leandro Tristao und 1 weiteren Autor:innen. Beteiligte Einrichtung: McMaster University, Hamilton, Ontario, Canada. Die Arbeit nennt 9 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Liver Imaging Reporting and Data System (LI-RADS) was developed to standardize imaging reporting and diagnosis of hepatocellular carcinoma (HCC) in at-risk populations while preserving specificity through the designation of observations that are malignant but not specific for HCC as LR-M. Since its introduction, LR-M has been recognized as a heterogeneous category encompassing tumors with diverse histopathologic substrates and clinical behavior. Prior investigations have consistently shown that LR-M observations are associated with poorer outcomes compared with LR-4 or LR-5 observations, particularly in patients undergoing curative-intent therapy, yet the internal heterogeneity of LR-M has remained incompletely characterized [1–3]. The study by Shanbhogue et al. [4] directly addresses this gap by evaluating clinicopathologic and prognostic differences between targetoid and nontargetoid LR-M observations on dynamic contrast-enhanced MRI, thereby advancing the understanding of imaging phenotype as a determinant of tumor biology and outcome. Earlier work established the adverse prognostic implications of the LR-M category as a whole. An et al. [1] demonstrated that LR-M classification portends worse survival after curative resection of a single primary hepatic malignancy, independent of histologic subtype. Subsequent studies confirmed that patients with LR-M tumors

Autor:innen und Institutionen

  • McMaster University, Hamilton, Ontario, Canada.
  • Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, Hamilton, Ontario, Canada.

ORCID-Profile: Christian B van der Pol

Zitieren

APA

Tristao, L., & van der Pol, C. B. (2026). Editorial for “Clinicopathologic and Prognostic Differences Between LI ‐ RADS M Targetoid and LI ‐ RADS M Nontargetoid Observations: A Comparative Imaging‐Based Study”. Journal of Magnetic Resonance Imaging, 63(6), 1711-1712. https://doi.org/10.1002/jmri.70290

Vancouver

Tristao L, van der Pol CB. Editorial for “Clinicopathologic and Prognostic Differences Between LI ‐ RADS M Targetoid and LI ‐ RADS M Nontargetoid Observations: A Comparative Imaging‐Based Study”. Journal of Magnetic Resonance Imaging. 2026;63(6):1711-1712. doi:10.1002/jmri.70290

BibTeX
@article{Tristao2026,
  author = {Tristao, Leandro and van der Pol, Christian B},
  title = {Editorial for “Clinicopathologic and Prognostic Differences Between LI ‐ RADS M Targetoid and LI ‐ RADS M Nontargetoid Observations: A Comparative Imaging‐Based Study”},
  journal = {Journal of Magnetic Resonance Imaging},
  year = {2026},
  volume = {63},
  number = {6},
  pages = {1711--1712},
  doi = {10.1002/jmri.70290}
}
Kostenlos starten →